Hasil Filter

2

Total database: 17430
Struktur (SMILES)
0 (0%)
Target
2 (100.0%)
Genomik
0 (0%)
Referensi
2 (100.0%)

Tipe Molekul

Distribusi Wujud Zat

Status Regulasi

Hasil Pencarian (2)

Lebrikizumab Approved DB11914
biotech | CAS: 953400-68-5

Lebrikizumab is a monoclonal antibody that binds to IL-13 with high affinity and slow off-rate.[L51374] It binds to a different epitope compared [tralokinumab].[A262874,A262879] On November 17, 2023, lebrikizumab was approved by the EMA under the brand nam…

Kategori:
Agents for Dermatitis, Excluding CorticosteroidsAmino Acids, Peptides, and ProteinsAntibodies +10
Target Protein:
Interleukin-13
Waktu ParuhThe mean eliminatio…
Vol. DistribusiBased on a populati…
KlirensIn the population P…
Genetik -
Tralokinumab Approved DB12169
biotech | CAS: 1044515-88-9

Atopic dermatitis (AD) is an inflammatory skin disorder that causes skin inflammation, skin barrier dysfunction, and chronic pruritus.[A242432] It is estimated to affect up to 20% of adults and children worldwide, and is frequently associated with other atopi…

Kategori:
Agents for Dermatitis, Excluding CorticosteroidsAmino Acids, Peptides, and ProteinsAntibodies +9
Target Protein:
Interleukin-13
Waktu ParuhThe half-life of tr…
Vol. DistribusiThe volume of distr…
KlirensThe clearance of tr…
Genetik -